Raphael Pharmaceutical Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 0.417 million compared to USD 0.627 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.05 a year ago.
For the six months, net loss was USD 0.681 million compared to USD 0.812 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.06 a year ago.